AU761647B2 - New benzoxazoles with PDE-inhibiting activity - Google Patents

New benzoxazoles with PDE-inhibiting activity Download PDF

Info

Publication number
AU761647B2
AU761647B2 AU47786/99A AU4778699A AU761647B2 AU 761647 B2 AU761647 B2 AU 761647B2 AU 47786/99 A AU47786/99 A AU 47786/99A AU 4778699 A AU4778699 A AU 4778699A AU 761647 B2 AU761647 B2 AU 761647B2
Authority
AU
Australia
Prior art keywords
compound
compounds
formula
hydroxyl
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU47786/99A
Other languages
English (en)
Other versions
AU4778699A (en
Inventor
Hermann Amschler
Thomas Bar
Rolf Beume
Hildegard Boss
Dieter Flockerzi
Beate Gutterer
Dietrich Hafner
Armin Hatzelmann
Hans-Peter Kley
Thomas Martin
Ulrich Thibaut
Wolf-Rudiger Ulrich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda GmbH
Original Assignee
Altana Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma AG filed Critical Altana Pharma AG
Publication of AU4778699A publication Critical patent/AU4778699A/en
Assigned to ALTANA PHARMA AG reassignment ALTANA PHARMA AG Amend patent request/document other than specification (104) Assignors: BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH
Application granted granted Critical
Publication of AU761647B2 publication Critical patent/AU761647B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU47786/99A 1998-07-06 1999-06-26 New benzoxazoles with PDE-inhibiting activity Ceased AU761647B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98112469 1998-07-06
EP98112469 1998-07-06
PCT/EP1999/004451 WO2000001695A1 (en) 1998-07-06 1999-06-26 New benzoxazoles with pde-inhibiting activity

Publications (2)

Publication Number Publication Date
AU4778699A AU4778699A (en) 2000-01-24
AU761647B2 true AU761647B2 (en) 2003-06-05

Family

ID=8232222

Family Applications (1)

Application Number Title Priority Date Filing Date
AU47786/99A Ceased AU761647B2 (en) 1998-07-06 1999-06-26 New benzoxazoles with PDE-inhibiting activity

Country Status (14)

Country Link
US (1) US6376485B1 (cg-RX-API-DMAC7.html)
EP (1) EP1095040B1 (cg-RX-API-DMAC7.html)
JP (1) JP2002519423A (cg-RX-API-DMAC7.html)
AT (1) ATE263166T1 (cg-RX-API-DMAC7.html)
AU (1) AU761647B2 (cg-RX-API-DMAC7.html)
CA (1) CA2336894A1 (cg-RX-API-DMAC7.html)
DE (1) DE69916066T2 (cg-RX-API-DMAC7.html)
DK (1) DK1095040T3 (cg-RX-API-DMAC7.html)
ES (1) ES2219031T3 (cg-RX-API-DMAC7.html)
IL (1) IL140468A0 (cg-RX-API-DMAC7.html)
PT (1) PT1095040E (cg-RX-API-DMAC7.html)
SI (1) SI1095040T1 (cg-RX-API-DMAC7.html)
WO (1) WO2000001695A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200100088B (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA83620C2 (ru) 2001-12-05 2008-08-11 Уайт Замещенные бензоксазолы и их аналоги как эстрогенные агенты
EP2275096A3 (en) 2005-08-26 2011-07-13 Braincells, Inc. Neurogenesis via modulation of the muscarinic receptors
EP2258357A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
WO2007047978A2 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by pde inhibition
EP2314289A1 (en) 2005-10-31 2011-04-27 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US7678808B2 (en) 2006-05-09 2010-03-16 Braincells, Inc. 5 HT receptor mediated neurogenesis
EP2021000A2 (en) 2006-05-09 2009-02-11 Braincells, Inc. Neurogenesis by modulating angiotensin
WO2008030651A1 (en) 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
JP5529746B2 (ja) * 2007-11-21 2014-06-25 デコード ジェネティクス イーエイチエフ 炎症性疾患、心臓血管疾患及び中枢神経系障害を治療するための置換されたベンゾアゾールpde4阻害剤
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
WO2013106547A1 (en) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405633A (en) * 1982-03-01 1983-09-20 Usv Pharmaceutical Corporation Method of treatment of asthma
US4490373A (en) * 1983-05-20 1984-12-25 Usv Pharmaceutical Corporation Method of treating asthma
AU699489B2 (en) * 1994-10-12 1998-12-03 Euro-Celtique S.A. Novel benzoxazoles
ATE230404T1 (de) * 1995-05-18 2003-01-15 Altana Pharma Ag Cyclohexyldihydrobenzofurane
HK1000785A1 (en) * 1995-05-19 2006-06-30 Kyowa Hakko Kogyo Co., Ltd Oxygen-containing heterocyclic compounds

Also Published As

Publication number Publication date
US6376485B1 (en) 2002-04-23
DK1095040T3 (da) 2004-07-26
DE69916066D1 (de) 2004-05-06
JP2002519423A (ja) 2002-07-02
PT1095040E (pt) 2004-08-31
ES2219031T3 (es) 2004-11-16
ZA200100088B (en) 2002-05-06
AU4778699A (en) 2000-01-24
WO2000001695A1 (en) 2000-01-13
DE69916066T2 (de) 2005-02-24
EP1095040B1 (en) 2004-03-31
CA2336894A1 (en) 2000-01-13
ATE263166T1 (de) 2004-04-15
EP1095040A1 (en) 2001-05-02
IL140468A0 (en) 2002-02-10
SI1095040T1 (en) 2004-10-31

Similar Documents

Publication Publication Date Title
US6410551B1 (en) Tetrazole derivatives
US20060116518A1 (en) Novel phenanthridines
EP0941221B1 (en) Substituted dihydrobenzofurans as pde inhibitors
EP1095040B1 (en) New benzoxazoles with pde-inhibiting activity
AU757198B2 (en) Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors
US6534518B1 (en) Polysubstituted 6-phenylphenanthridines with PDE-IV inhibiting activity
US6534519B1 (en) Phenanthridine-N-oxides with PDE-IV inhibiting activity
US6214839B1 (en) Substituted 6-alkylphenanthridines
EP1147088B1 (en) 6-arylphenanthridines with pde-iv inhibiting activity
US6538005B2 (en) Phenanthridine-N-oxides with PDE-IV inhibiting activity
WO2002005616A1 (en) Novel 6-phenylphenanthridines
EP1303506B1 (en) 6-heteroarylphenanthridines
AU782908B2 (en) Phenanthridine-N-oxides
WO2002006238A1 (en) Cycloalkyl - or cycloalkylmethyl-substituted 6-phenylphenanthridines
AU2005220034A1 (en) Novel isoamido-substituted hydroxy-6-phenylphenanthridines and their use as PDE4 inhibitors
WO2002006239A1 (en) Phenanthridine n-oxides
AU3825099A (en) Novel benzimidazoles and benzoxazoles

Legal Events

Date Code Title Description
TC Change of applicant's name (sec. 104)

Owner name: ALTANA PHARMA AG

Free format text: FORMER NAME: BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH

FGA Letters patent sealed or granted (standard patent)